Krishna Institute of Medical Sciences Other Announcement
KIMS's CARE Ratings monitoring report shows ₹1,311.81 crore of the ₹1,476.45 crore QIP proceeds utilised till Q2 FY27. No deviation from the stated objects was reported.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
7 announcements with these filters
KIMS's CARE Ratings monitoring report shows ₹1,311.81 crore of the ₹1,476.45 crore QIP proceeds utilised till Q2 FY27. No deviation from the stated objects was reported.
The company filed its quarterly shareholding pattern for the quarter ended September 30, 2026, in compliance with SEBI regulations.
KIMS provided additional information regarding the board meeting held on October 06, 2026, in response to a BSE query.
Krishna Institute of Medical Sciences Limited filed its Monitoring Agency Report for the quarter ended June 30, 2026, confirming no material deviations in QIP proceeds utilization.
Krishna Institute of Medical Sciences Ltd filed its quarterly shareholding pattern for the period ending June 30, 2026. The filing details the distribution of equity shares among various stakeholders.
Krishna Institute of Medical Sciences filed its audited standalone and consolidated financial statements for FY2026. The statutory audit report is enclosed following board approval.
Krishna Institute of Medical Sciences Limited filed its Annual Secretarial Compliance Report for FY 2025-26. The auditor reported no material non-compliances or fines.